Using Mass Spectrometry to Study Opioid Effects on Mouse Fetuses
Author Information
Author(s): Barnette Dustyn, Inselman Amy L., Kaldhone Pravin, Lee Grace S., Davis Kelly, Sarkar Sumit, Malhi Pritpal, Fisher J. Edward, Hanig Joseph P., Beger Richard D., Jones E. Ellen
Primary Institution: National Center for Toxicological Research (FDA)
Hypothesis
The study aims to assess the impact of in utero opioid exposure on lipid distributions in mouse fetuses using MALDI mass spectrometry imaging.
Conclusion
The study found that maternal exposure to morphine and valproic acid led to differential lipid distributions in mouse fetuses, which may indicate potential molecular mechanisms of opioid-related developmental effects.
Supporting Evidence
- Maternal opioid use has been linked to a two-fold increase in neural tube defects in fetuses.
- MALDI MSI can visualize lipid distributions across tissue sections.
- Differential lipid distributions were observed in the brains and spinal cords of mouse fetuses exposed to opioids.
- Specific lipids were identified as potential markers for further investigation of opioid-related developmental effects.
Takeaway
Researchers looked at how opioids affect baby mice by checking the fats in their brains, finding that opioids change where these fats are located.
Methodology
The study used MALDI mass spectrometry imaging to analyze lipid distributions in mouse fetuses exposed to morphine and valproic acid.
Limitations
The inability to detect parent drugs in fetuses due to the timing of sample collection post-dosing.
Participant Demographics
Timed-pregnant CF-1 mice were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website